https://doi.org/10.7490/f1000research.1118646.1
Poster
NOT PEER REVIEWED
Download
metrics
VIEWS
252
 
downloads
9
CITE
How to cite this poster:
Campbell C, Wang T, Barnes E and Matthews PC. Baseline risk factors for liver cancer development in a large multisite chronic HBV electronic health record-based cohort in the UK [version 1; not peer reviewed]. F1000Research 2021, 10:653 (poster) (https://doi.org/10.7490/f1000research.1118646.1)
NOTE: it is important to ensure the information in square brackets after the title is included in this citation.

Baseline risk factors for liver cancer development in a large multisite chronic HBV electronic health record-based cohort in the UK

Cori Campbell, Tingyan Wang, Eleanor Barnes, Philippa C. Matthews1
Author Affiliations
  • Metrics
  • 252 Views
  • 9 Downloads
 
Browse by related subjects
Published 26 Jul 2021

Baseline risk factors for liver cancer development in a large multisite chronic HBV electronic health record-based cohort in the UK

[version 1; not peer reviewed]

Cori Campbell, Tingyan Wang, Eleanor Barnes, Philippa C. Matthews1
Author Affiliations
1 University of Oxford, UK
Presented at
31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), 2021
Abstract
Competing Interests

This project involves data derived from patient-level information collected by the NHS, as part of the care and support of cancer patients. The data is collated, maintained and quality assured by the National Cancer Registration and Analysis Service, which is part of Public Health England (PHE). Access to the data was facilitated by the PHE Office for Data Release. We acknowledge the contribution of EMIS practices who contribute to QResearch® and EMIS Health and the CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD for expertise in establishing, developing and supporting the QResearch database. Public Health England bear no responsibility for the analysis or interpretation of the data. Cori Campbell acknowledges doctoral funding from the Nuffield Department of Medicine, University of Oxford and GlaxoSmithKline. Philippa C. Matthews acknowledges funding from theWellcome Trust (grant no. 1101).

Keywords
HBV, epidemiology
Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.